Funding News - Persons with Primary Progressive Multiple Sclerosis Sought for Study

Historical Data

The information on this page is for historical and research purposes only.
For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

NINDS is seeking persons with primary progressive multiple sclerosis for participation in a research study on the efficacy of an experimental oral drug. The study will involve a 1-year baseline period after which participants will receive the study medication or placebo (an inactive substance) for 2 years. Medical evaluations, MRIs, and bloodwork will be performed at scheduled intervals during the 3-year study.

Participants must be 18 to 55 years of age with a diagnosis of primary progressive multiple sclerosis and not taking any immunomodulatory drugs.

The study will take place at the NIH Clinical Center in Bethesda, MD. Visits will last 2-5 hours each and will be every month for the first 3 months and then every 6 months for the remainder of the study. There is no cost for participation or for any study-related tests. Transportation reimbursement will be provided.

For more information, contact Joan Ohayon at 301-496-0064. Please refer to study number 09-N-0197.